secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001628280-23-023215
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive stockholders elect directors, approve equity plan, reject charter amendment at 2023 annual meeting
--------------------------------------------------------------------------------

- Gregory B. Brown and John S. Cochran elected as Class II directors with over 24.7M and 24.9M votes for, respectively.
- Amendment to 2018 Equity Incentive Plan approved: 18.97M for, 7.27M against, 0.34M abstain.
- Amendment to Amended and Restated Certificate of Incorporation not approved: 22.31M for, 3.25M against, 1.02M abstain (failed to meet required threshold).
- Ratification of KPMG LLP as independent auditor for FY2023 approved: 40.09M for, 0.44M against, 0.20M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828023023215/0001628280-23-023215-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828023023215/aqst-20230623.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-023215

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer